Karyopharm Therapeutics Inc. (KPTI) Revenue 2016–2025
Karyopharm Therapeutics Inc. (KPTI) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$146.1MFY2025 · since FY2016: $154,000 → $146.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $146.1M | +0.6% |
| FY2024 | $145.2M | -0.5% |
| FY2023 | $146.0M | -7.0% |
| FY2022 | $157.1M | -25.1% |
| FY2021 | $209.8M | +94.1% |
| FY2020 | $108.1M | +164.3% |
| FY2019 | $40.9M | +34.8% |
| FY2018 | $30.3M | +1790.1% |
| FY2017 | $1.6M | +942.2% |
| FY2016 | $154,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice